Company: Integrated Nanotherapeutics Inc.
Job title: Co-Founder & Director - Preclinical Development
Harnessing a Multi-Cargo LNP Technology to Enable Antigen Specific Immune Tolerance 9:30 am
Outlining a multi-cargo LNP approach that enables mRNA-LNPs for immune tolerance Showcasing proof-of-concept in preclinical type 1 diabetes models Investigating the immunological mechanisms induced by multi-cargo LNPsRead more
day: Conference Day Two